Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells-Reference-Cited by-同舟云学术

Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells

Published:2010-11 Issue:1 Volume:297 Page:42-48
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Wang Ling,Ling Yun,Chen Yan,Li Cheng-Ling,Feng Feng,You Qi-Dong,Lu Na,Guo Qing-Long

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen;So;Cancer Lett.,1997

2. The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase;Yano;Cancer Res.,1994

3. Antitumor effects of saikosaponins, baicalin and baicalein on human hepatoma cell lines;Motoo;Cancer Lett.,1994

4. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo;Liu;J. Urol.,2000

5. Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and wogonin on bladder cancer cell lines;Ikemoto;Urology,2000

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD44/PD-L1-mediated networks in drug resistance and immune evasion of breast cancer stem cells: Promising targets of natural compounds;International Immunopharmacology;2024-09

2. The most recent progress of baicalein in its anti-neoplastic effects and mechanisms;Biomedicine & Pharmacotherapy;2024-07

3. Therapeutic efficacy and anti-inflammatory mechanism of baicalein on endometriosis progression in patient-derived cell line and mouse model;Phytomedicine;2024-07

4. EGFR and Hippo signaling pathways are involved in organophosphate esters–induced proliferation and migration of triple-negative breast cancer cells;Environmental Science and Pollution Research;2024-06-10

5. Natural Products as Regulators against Matrix Metalloproteinases for the Treatment of Cancer;Biomedicines;2024-04-03